These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25682281)

  • 1. Failure to detect carbapenem-resistant Escherichia coli producing OXA-48-like using the Xpert Carba-R assay®.
    Decousser JW; Poirel L; Desroches M; Jayol A; Denamur E; Nordmann P
    Clin Microbiol Infect; 2015 Feb; 21(2):e9-10. PubMed ID: 25682281
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of OXA-48-like carbapenemase genes by the Xpert® Carba-R test: room for improvement.
    Lafeuille E; Laouira S; Sougakoff W; Soulier-Escrihuela O; Leconte J; Garrec H; Tourret J; Jarlier V; Robert J
    Int J Antimicrob Agents; 2015 Apr; 45(4):441-2. PubMed ID: 25601530
    [No Abstract]   [Full Text] [Related]  

  • 3. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
    Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
    Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and biochemical characterisation of OXA-232, a carbapenem-hydrolysing class D β-lactamase from Enterobacteriaceae.
    Potron A; Rondinaud E; Poirel L; Belmonte O; Boyer S; Camiade S; Nordmann P
    Int J Antimicrob Agents; 2013 Apr; 41(4):325-9. PubMed ID: 23305656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss.
    Gülmez D; Woodford N; Palepou MF; Mushtaq S; Metan G; Yakupogullari Y; Kocagoz S; Uzun O; Hascelik G; Livermore DM
    Int J Antimicrob Agents; 2008 Jun; 31(6):523-6. PubMed ID: 18339523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbapenem resistance among Escherichia coli and Klebsiella pneumoniae in a tertiary care hospital in south India.
    Nagaraj S; Chandran SP; Shamanna P; Macaden R
    Indian J Med Microbiol; 2012; 30(1):93-5. PubMed ID: 22361769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of extended-spectrum, AmpC, and carbapenem- hydrolyzing beta-lactamases in Escherichia coli and Klebsiella pneumoniae by disk tests.
    Jacoby GA; Walsh KE; Walker VJ
    J Clin Microbiol; 2006 Jun; 44(6):1971-6. PubMed ID: 16757586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of carbapenem-resistant Escherichia coli producing CMY-2-type AmpC beta-lactamase in Brazil.
    Pavez M; Neves P; Dropa M; Matté MH; Grinbaum RS; Elmor de Araújo MR; Mamizuka EM; Lincopan N
    J Med Microbiol; 2008 Dec; 57(Pt 12):1590-1592. PubMed ID: 19018036
    [No Abstract]   [Full Text] [Related]  

  • 9. OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii.
    Amudhan SM; Sekar U; Arunagiri K; Sekar B
    Indian J Med Microbiol; 2011; 29(3):269-74. PubMed ID: 21860108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First detection of a carbapenem-hydrolyzing metalloenzyme in two enterobacteriaceae isolates in Spain.
    Tórtola MT; Lavilla S; Miró E; González JJ; Larrosa N; Sabaté M; Navarro F; Prats G
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3492-4. PubMed ID: 16048967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of OXA-143 and alteration of outer membrane proteins in carbapenem-resistant Acinetobacter spp. isolates in Brazil.
    Mostachio AK; Levin AS; Rizek C; Rossi F; Zerbini J; Costa SF
    Int J Antimicrob Agents; 2012 May; 39(5):396-401. PubMed ID: 22455794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of blaKPC-2 in a carbapenem-resistant Kluyvera georgiana.
    Ribeiro VB; Zavascki AP; Nodari CS; Sandri AM; Silva MP; Campos JC; Sampaio JL; Barth AL
    J Antimicrob Chemother; 2012 Nov; 67(11):2776-7. PubMed ID: 22850690
    [No Abstract]   [Full Text] [Related]  

  • 13. Dissemination of carbapenemase-producing Enterobacteriaceae in France, 2012.
    Dortet L; Cuzon G; Nordmann P
    J Antimicrob Chemother; 2014 Mar; 69(3):623-7. PubMed ID: 24275115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam.
    Pitout JD; Le P; Church DL; Gregson DB; Laupland KB
    Int J Antimicrob Agents; 2008 Oct; 32(4):333-8. PubMed ID: 18701262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Widespread Dissemination of Carbapenem-Resistant Escherichia coli Sequence Type 167 Strains Harboring blaNDM-5 in Clinical Settings in China.
    Huang Y; Yu X; Xie M; Wang X; Liao K; Xue W; Chan EW; Zhang R; Chen S
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4364-8. PubMed ID: 27114282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of OXA-48 carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in dogs.
    Stolle I; Prenger-Berninghoff E; Stamm I; Scheufen S; Hassdenteufel E; Guenther S; Bethe A; Pfeifer Y; Ewers C
    J Antimicrob Chemother; 2013 Dec; 68(12):2802-8. PubMed ID: 23833179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular surveillance and clinical outcomes of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae infections.
    Huang SR; Liu MF; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2014 Jun; 47(3):187-96. PubMed ID: 23200553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenem resistance due to Bla(OXA-48) among ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates in a univesity hospital, Turkey.
    Nazik H; Ongen B; Ilktac M; Aydin S; Kuvat N; Sahin A; Yemisen M; Mete B; Durmus MS; Balkan II; Yildiz I; Ergul Y
    Southeast Asian J Trop Med Public Health; 2012 Sep; 43(5):1178-85. PubMed ID: 23431824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems using an in vitro model.
    Zhanel GG; Baudry PJ; Tailor F; Cox L; Hoban DJ; Karlowsky JA
    J Antimicrob Chemother; 2009 Oct; 64(4):824-8. PubMed ID: 19643776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Carbapenem-resistant Escherichia coli now exist in Sweden].
    Ljungquist O; Kjölvmark C; Tängdén T
    Lakartidningen; 2013 Aug 7-20; 110(32-33):1401-2. PubMed ID: 23980379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.